Madrigal Pharmaceuticals Q4 EPS $(3.78) Up From $(3.82) YoY

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.78) per share. This is a 1.05 percent increase over losses of $(3.82) per share from the same period last year.

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.78) per share. This is a 1.05 percent increase over losses of $(3.82) per share from the same period last year.

Total
0
Shares
Related Posts